298 related articles for article (PubMed ID: 34498718)
1. Metastatic pancreatic cancer: Mechanisms and detection (Review).
Chen X; Liu F; Xue Q; Weng X; Xu F
Oncol Rep; 2021 Nov; 46(5):. PubMed ID: 34498718
[TBL] [Abstract][Full Text] [Related]
2. Risk factors, biomarker and imaging techniques used for pancreatic cancer screening.
Thomas C
Chin Clin Oncol; 2017 Dec; 6(6):61. PubMed ID: 29307201
[TBL] [Abstract][Full Text] [Related]
3. What's new in the diagnosis of pancreatic cancer: a patent review (2011-present).
Boulaiz H; Ramos MC; Griñán-Lisón C; García-Rubiño ME; Vicente F; Marchal JA
Expert Opin Ther Pat; 2017 Dec; 27(12):1319-1328. PubMed ID: 28929814
[TBL] [Abstract][Full Text] [Related]
4. A Social Program for the Early Detection of Pancreatic Cancer: The Kishiwada Katsuragi Project.
Sakamoto H; Harada S; Nishioka N; Maeda K; Kurihara T; Sakamoto T; Higuchi K; Kitano M; Takeyama Y; Kogire M; Kudo M
Oncology; 2017; 93 Suppl 1():89-97. PubMed ID: 29258101
[TBL] [Abstract][Full Text] [Related]
5. Advances in biomarker research for pancreatic cancer.
Bhat K; Wang F; Ma Q; Li Q; Mallik S; Hsieh TC; Wu E
Curr Pharm Des; 2012; 18(17):2439-51. PubMed ID: 22372502
[TBL] [Abstract][Full Text] [Related]
6. Macrophage inhibitory cytokine-1/growth differentiation factor-15 in premalignant and neoplastic tumours in a high-risk pancreatic cancer cohort.
O'Neill RS; Emmanuel S; Williams D; Stoita A
World J Gastroenterol; 2020 Apr; 26(14):1660-1673. PubMed ID: 32327914
[TBL] [Abstract][Full Text] [Related]
7. The pathology and genetics of metastatic pancreatic cancer.
Yachida S; Iacobuzio-Donahue CA
Arch Pathol Lab Med; 2009 Mar; 133(3):413-22. PubMed ID: 19260747
[TBL] [Abstract][Full Text] [Related]
8. Prospective Follow-up Study of the Recurrence of Pancreatic Cancer Diagnosed at an Early Stage: The Value of Endoscopic Ultrasonography for Early Diagnosis of Recurrence in the Remnant Pancreas.
Ikemoto J; Hanada K; Minami T; Okazaki A; Abe T; Amano H; Yonehara S
Pancreas; 2018 Apr; 47(4):482-488. PubMed ID: 29517631
[TBL] [Abstract][Full Text] [Related]
9. New strategies for the early detection of pancreatic cancer.
Petrone MC; Arcidiacono PG
Expert Rev Gastroenterol Hepatol; 2016; 10(2):157-9. PubMed ID: 26582179
[TBL] [Abstract][Full Text] [Related]
10. Immuno-OpenPET: a novel approach for early diagnosis and image-guided surgery for small resectable pancreatic cancer.
Yoshii Y; Tashima H; Iwao Y; Yoshida E; Wakizaka H; Akamatsu G; Yamaya T; Matsumoto H; Yoshimoto M; Igarashi C; Hihara F; Tachibana T; Zhang MR; Nagatsu K; Sugyo A; Tsuji AB; Higashi T
Sci Rep; 2020 Mar; 10(1):4143. PubMed ID: 32157106
[TBL] [Abstract][Full Text] [Related]
11. Imaging features of hematogenous metastases to the pancreas: pictorial essay.
Tan CH; Tamm EP; Marcal L; Balachandran A; Charnsangavej C; Vikram R; Bhosale P
Cancer Imaging; 2011 Mar; 11(1):9-15. PubMed ID: 21367687
[TBL] [Abstract][Full Text] [Related]
12. A Quest for Survival: A Review of the Early Biomarkers of Pancreatic Cancer and the Most Effective Approaches at Present.
Bestari MB; Joewono IR; Syam AF
Biomolecules; 2024 Mar; 14(3):. PubMed ID: 38540782
[TBL] [Abstract][Full Text] [Related]
13. Detection of Circulating Tumor Cells Using Negative Enrichment Immunofluorescence and an In Situ Hybridization System in Pancreatic Cancer.
Xu Y; Qin T; Li J; Wang X; Gao C; Xu C; Hao J; Liu J; Gao S; Ren H
Int J Mol Sci; 2017 Mar; 18(4):. PubMed ID: 28333072
[TBL] [Abstract][Full Text] [Related]
14. Endoscopic ultrasound-guided fine-needle aspirate-derived preclinical pancreatic cancer models reveal panitumumab sensitivity in KRAS wild-type tumors.
Berry W; Algar E; Kumar B; Desmond C; Swan M; Jenkins BJ; Croagh D
Int J Cancer; 2017 May; 140(10):2331-2343. PubMed ID: 28198009
[TBL] [Abstract][Full Text] [Related]
15. The role of pancreatic cancer-derived exosomes in cancer progress and their potential application as biomarkers.
Jin H; Wu Y; Tan X
Clin Transl Oncol; 2017 Aug; 19(8):921-930. PubMed ID: 28168600
[TBL] [Abstract][Full Text] [Related]
16. Early diagnosis of pancreatic cancer: challenges and new developments.
Kaur S; Baine MJ; Jain M; Sasson AR; Batra SK
Biomark Med; 2012 Oct; 6(5):597-612. PubMed ID: 23075238
[TBL] [Abstract][Full Text] [Related]
17. Advances in understanding the molecular mechanism of pancreatic cancer metastasis.
Du YX; Liu ZW; You L; Wu WM; Zhao YP
Hepatobiliary Pancreat Dis Int; 2016 Aug; 15(4):361-70. PubMed ID: 27498575
[TBL] [Abstract][Full Text] [Related]
18. Serum dickkopf-1 is a novel serological biomarker for the diagnosis and prognosis of pancreatic cancer.
Han SX; Zhou X; Sui X; He CC; Cai MJ; Ma JL; Zhang YY; Zhou CY; Ma CX; Varela-Ramirez A; Zhu Q
Oncotarget; 2015 Aug; 6(23):19907-17. PubMed ID: 26101916
[TBL] [Abstract][Full Text] [Related]
19. Diagnostic strategies for early pancreatic cancer.
Hanada K; Okazaki A; Hirano N; Izumi Y; Teraoka Y; Ikemoto J; Kanemitsu K; Hino F; Fukuda T; Yonehara S
J Gastroenterol; 2015 Feb; 50(2):147-54. PubMed ID: 25501287
[TBL] [Abstract][Full Text] [Related]
20. Pancreatic cancer screening in high-risk individuals with germline genetic mutations.
DaVee T; Coronel E; Papafragkakis C; Thaiudom S; Lanke G; Chakinala RC; Nogueras González GM; Bhutani MS; Ross WA; Weston BR; Lee JH
Gastrointest Endosc; 2018 Jun; 87(6):1443-1450. PubMed ID: 29309780
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
